AI Product

Ultromics — Medical Imaging

EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.

Product Ecosystem Map

How this product connects across company, capabilities, technology, and markets on Brel.

Overview

What this product is, what it does, and who develops it.

With a focus on optimizing clinical department throughput while lowering documentation fatigue, Ultromics — Medical Imaging is an artificial intelligence platform created by Ultromics. The software applies advanced computational techniques to evaluating multi-modal patient care metrics with statistical rigor, reducing inconsistent pathological classification and clinical documentation burden.

Oxford echocardiography AI company with FDA-cleared EchoGo platform for heart failure and cardiac amyloidosis detection from standard ultrasound

What it does

EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.

Who develops it

Cardiology departments, echo labs, health systems including UChicago Medicine and Mayo Clinic partners, and NHS cardiovascular pathways seeking AI-enhanced echo interpretation.

Capabilities & Features

Verified capabilities and product features from the Brel product record.

Capabilities

  • EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.

Technology & Architecture

Technologies, models, and technical structure linked to this product.

The platform operates as a continuous intelligence pipeline, transforming disparate inputs into structured outputs. Through rigorous evaluating multi-modal patient care metrics with statistical rigor, Ultromics — Medical Imaging ensures that organizations maintain peak operational readiness.

Use Cases

Where this product is applied in real operational contexts.

  • EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.
  • Medical Imaging: Automating multi-step verification to enhance outcome reliability.

Who It Is For

Target users, industries, and deployment context.

Cardiology departments, echo labs, health systems including UChicago Medicine and Mayo Clinic partners, and NHS cardiovascular pathways seeking AI-enhanced echo interpretation.

Industries

Industries served

  • AI in Healthcare
  • Medical Imaging

Enterprise buyers and technical teams, data leaders, and operational specialists in Healthcare utilize Ultromics — Medical Imaging across mission-critical workflows. Systems administrators can configure the platform within hardened healthcare cloud VPCs adhering to SOC 2 Type II controls.

Integrations & Deployment

Integration surface and how the product is deployed.

Enterprises can integrate Ultromics — Medical Imaging into existing operational stacks via modular connectors, secure webhooks, and programmatic SDKs. This ensures cohesive synchronization between the AI platform and downstream reporting systems.

Developer

API, documentation, GitHub, and technical resources when verified.

Developer / Company

The organization that builds and ships this product.

As an artificial intelligence offering from Ultromics (Oxford, United Kingdom established in 2017 by Ross Upton), Ultromics — Medical Imaging addresses core operational requirements across Healthcare.

Recent Organizational Milestones: 2017: Ultromics founded in Oxford by Ross Upton, PhD, spinning out of University of Oxford research with Professor Paul Leeson. November 14, 2019: FDA 510(k) clearance for EchoGo Core strain and ejection fraction analysis. July 31, 2025: Ultromics raised $55 million Series C co-led by L&G, Allegis Capital, and Lightrock. 2025–2026: EchoGo Heart Failure probability scoring and cardiac amyloidosis models expanded with Medicare reimbursement.

Frequently Asked Questions

Answers restated from verified fields on this product profile.

What is the primary function of Ultromics — Medical Imaging?

Ultromics — Medical Imaging is an AI solution developed by Ultromics, designed to deliver standardizing institutional care delivery and clinical audit compliance by systematizing synthesizing high-dimensional clinical telemetry.

Who developed Ultromics — Medical Imaging?

Ultromics — Medical Imaging is built and maintained by Ultromics, based in Oxford, United Kingdom.

What key capabilities are documented for Ultromics — Medical Imaging?

Documented capabilities include: EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA; reimbursed probability scoring integrated into clinical workflows; EchoGo applies deep learning to standard echocardiogram DICOM studies, generating real.

How does Ultromics — Medical Imaging utilize artificial intelligence?

Ultromics — Medical Imaging utilizes Machine Learning, Deep Learning, Predictive Analytics, Medical Imaging, Healthcare Analytics, supporting deployment across secured electronic health record (EHR) FHIR interface layers.

Which organizations deploy Ultromics — Medical Imaging?

The software is engineered for Cardiology departments, echo labs, health systems including UChicago Medicine and Mayo Clinic partners, and NHS cardiovascular pathways seeking AI-enhanced echo interpretation. seeking to mitigate unstructured electronic health record (EHR) data silos.

Sources & Verification

Verified
Last reviewed Jul 2026

Primary sources

Related Knowledge

Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.

Explore the Ecosystem

Enquire about this product profile

Messages are delivered to contact@breldigital.com.

In this product